DNA methylation estimates of immune cell abundance have prognostic potential in triple negative breast cancer.
1/5 보강
Immune infiltration is now recognised as an important prognostic factor in triple negative breast cancer (TNBC).
APA
Williams S, Korbie D, et al. (2026). DNA methylation estimates of immune cell abundance have prognostic potential in triple negative breast cancer.. Clinical epigenetics. https://doi.org/10.1186/s13148-026-02052-w
MLA
Williams S, et al.. "DNA methylation estimates of immune cell abundance have prognostic potential in triple negative breast cancer.." Clinical epigenetics, 2026.
PMID
41588527 ↗
Abstract 한글 요약
Immune infiltration is now recognised as an important prognostic factor in triple negative breast cancer (TNBC). DNA methylation, due to its cell-type specificity, offers a promising approach for quantifying immune cell abundance as a biomarker for risk stratification. Here, we used EpiDISH, a DNA methylation-based cellular deconvolution method, to estimate immune cell proportions from genome-wide methylation data across four independent breast cancer datasets. We show that increased methylation-estimated immune cell percentage in TNBC patients is associated with improved outcomes. This highlights the potential of DNA methylation-based estimates of cell composition for prognosis in TNBC.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (4)
- Cost-per-responder analysis of TAR-200 versus other Food and Drug Administration-approved novel and generic treatments among patients with Bacillus Calmette-Guérin-unresponsive, high-risk, non-muscle-invasive bladder cancer with carcinoma in situ in the United States.
- Efficacy of Mesh Use in Breast Surgery: A Comprehensive Review of Complications and Aesthetic Outcomes.
- Reviewing Outcomes and Complications with the Use of Mesh in Breast Reduction Surgery.
- How Well Do They Convert? Trending ASAPS Presentations to Publication From 1995-2010.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Novel roles of SETD2 in tumor metabolism and immunotherapy: a systematic review and meta-analysis.
- High-risk molecular features may eclipse genomic complexity in predicting chronic lymphocytic leukemia outcomes; UK clinical trial insights.
- Integrative multiomic profiling of cfDNA methylation and EV-miRNAs identifies immunotherapy-outcome molecular subtypes in NSCLC.
- Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphoma.
- BioLM-NET: an interpretable deep learning model combining prior biological knowledge and contextual LLM gene embeddings on multi-omics data to predict disease.
- Folate Intake and Breast Cancer Risk: A Systematic Review and Meta-Analysis.